P3 Health Partners Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2020	2019	2018
Revenue	1,266	1,049	485.54	145.89	87.7
Revenue Growth (YoY)	20.67%	116.14%	232.80%	66.36%	-
Cost of Revenue	1,222	1,046	464.97	147.81	106.66
Gross Profit	44.34	3.71	20.57	-1.91	-18.96
Selling, General & Admin	125.6	162.38	54.89	37.23	30.41
Other Operating Expenses	86.68	1,402	0.8	0.4	0.34
Operating Expenses	212.27	1,565	55.69	37.62	30.75
Operating Income	-167.93	-1,560.91	-35.12	-39.54	-49.71
Interest Expense / Income	15.99	11.4	9.97	3.48	-0.04
Other Expense / Income	-128.84	-1,304.05	-4.02	-8.01	-5.87
Pretax Income	-55.08	-268.27	-41.07	-35.01	-43.8
Income Tax	2.7	1.86	0	0	0
Net Income	-57.77	-270.13	-41.07	-35.01	-43.8
Shares Outstanding (Basic)	95	42	7	-	-
Shares Outstanding (Diluted)	295	42	7	-	-
Shares Change	608.51%	504.79%	-	-	-
EPS (Basic)	-0.61	-6.50	-0.62	-0.74	-1.78
EPS (Diluted)	-0.63	-6.50	-0.62	-0.74	-1.78
Free Cash Flow	-77.86	-128.25	-27.52	-29.74	-32.54
Free Cash Flow Per Share	-0.82	-3.08	-4.00	-	-
Gross Margin	3.50%	0.35%	4.24%	-1.31%	-21.62%
Operating Margin	-13.26%	-148.73%	-7.23%	-27.10%	-56.69%
Profit Margin	-4.56%	-25.74%	-8.46%	-24.00%	-49.95%
Free Cash Flow Margin	-6.15%	-12.22%	-5.67%	-20.38%	-37.11%
EBITDA	47.58	-169.57	-30.31	-31.13	-43.5
EBITDA Margin	3.76%	-16.16%	-6.24%	-21.34%	-49.61%
Depreciation & Amortization	86.68	87.29	0.8	0.4	0.34
EBIT	-39.09	-256.86	-31.1	-31.53	-43.85
EBIT Margin	-3.09%	-24.48%	-6.41%	-21.61%	-50.00%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).